HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consumer Health Fraud Didn’t Start With COVID-19, Senators And Witnesses Say At Hearing

Executive Summary

“Dietary supplements are among the most poorly regulated consumer products,” CSPI policy director tells Senate Manufacturing, Trade and Consumer Protection Subcommittee. Ranking member Blumenthal says scams won’t end soon. “We’re six months into this pandemic with no end in sight.”

You may also be interested in...

France Clamping Down On Unapproved COVID-19 Supplement Claims

France is warning consumers not to be taken in by unapproved health claims for food supplements related to treating or preventing COVID-19. The country's competition authority is clamping down on unscrupulous websites and companies offering "miracle" products for sale.

Sun Sets On California Firm: FTC Pandemic Fraud Complaint Follows Criminal Indictment

Golden Sunrise business owner Huu Tieu marketed a package of herbal mixtures branded “Emergency D-Virus Plan of Care” with claims to treat COVID-19, says FTC complaint. Tieu was indicted on criminal charges two weeks before FTC filed complaint.

House Democrats Add OTC Antibody Tests To COVID-19 Fraud Questions For US Regulators

Energy and Commerce Chairman Frank Pallone and four subcommittee chairs tell FTC and FDA that the degree to which COVID-19 antibodies protect against infection isn't known, but there's "significant demand for antibody tests among consumers who wish to return to their everyday activities against the advice of public health experts."

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts